IL17A and neoplasm: Importantly, IL17 and IL23 alongside IL22 and cell-autonomous acting IL21, all promote and stabilize the Th17 phenotype and sustain inflammation [138] through various Stat3-dependent feed-forward loops within the tumour, stromal and haematopoietic cells of the microenvironment [133] (Figure 4).